Literature DB >> 30105812

Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma.

Lianbo Zhang1, Haiyan Qin1, Zhuoxia Wu1, Wanying Chen1, Guang Zhang2.   

Abstract

BACKGROUND: Actinic keratosis (AK) is an incipient form of cutaneous squamous cell carcinoma (cSCC). Understanding the differentially expressed genes between AK and cSCC states would be helpful for the early prevention and treatment of cSCC. Consequently, this study aimed to screen the key genes associated with the progression of AK to cSCC.
METHODS: The microarray dataset GSE45216 was downloaded from the Gene Expression Omnibus, which included 10 AK and 30 primary cSCC skin tissue samples. Differentially expressed genes (DEGs) in cSCC samples, compared to those in AK, were identified. Gene co-expression relationships were investigated, followed by miRNA prediction. The potential functions of the co-expressed genes were predicted by gene ontology (GO) and pathway enrichment analyses. In addition, the transcription factors and drug molecules, significantly related to the co-expressed genes, were obtained.
RESULTS: A total of 320 DEGs were identified in the cSCC group, relative to the AK group. Moreover, 96 DEGs and 2,390 connecting edges were identified in the gene co-expression network. An miRNA regulatory network was constructed, including 96 DEGs and 16 miRNAs. In addition, three co-expression network modules were obtained; EIF4EBP1, SNX17, PRPF4, NXT1, and UBA5 were significant nodes in the modules.
CONCLUSIONS: EIF4EBP1, SNX17, PRPF4, NXT1, and UBA5 may be the pathogenic genes contributing to the development of cSCC from AK.
© 2018 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30105812     DOI: 10.1111/ijd.14131

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

Review 1.  Driving innovation for rare skin cancers: utilizing common tumours and machine learning to predict immune checkpoint inhibitor response.

Authors:  J S Hooiveld-Noeken; R S N Fehrmann; E G E de Vries; M Jalving
Journal:  Immunooncol Technol       Date:  2019-11-27

2.  Decreased TMEM40 expression is associated with malignant behavior of cutaneous squamous cell carcinoma and inhibits tumor progression.

Authors:  Lei Yu; Jie Liu; Tang-De Zhang; Xiu-Fen Zheng; Dong-Lan Luo; Wei-Liang Zhu; Xian-Wen Qiu; Lin-Lang Guo
Journal:  Oncol Lett       Date:  2021-06-15       Impact factor: 2.967

3.  Seven key hub genes identified by gene co-expression network in cutaneous squamous cell carcinoma.

Authors:  Huizhen Chen; Jiankang Yang; Wenjuan Wu
Journal:  BMC Cancer       Date:  2021-07-23       Impact factor: 4.430

4.  Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.

Authors:  Aleksandra Dańczak-Pazdrowska; Jakub Pazdrowski; Adriana Polańska; Brittany Basta; Augusto Schneider; Michał J Kowalczyk; Paweł Golusiński; Wojciech Golusiński; Zygmunt Adamski; Ryszard Żaba; Michal M Masternak
Journal:  Arch Dermatol Res       Date:  2021-04-04       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.